SCHEMBL427489

SCHEMBL427489

CN(C(=O)n1cnc(-c2ccccc2F)c1)c1ccc(F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.40
GPBAR1 Q8TDU6 3/20 0.40
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
MLNR O43193 1/20 0.37
AGTR2 P50052 2/20 0.37
GRIN2B Q13224 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
USP19 O94966 1/20 0.36
PIK3CA P42336 1/20 0.36
ADORA3 P0DMS8 2/20 0.36
ADORA2A P29274 2/20 0.36
ADORA2B P29275 1/20 0.36
ADORA1 P30542 1/20 0.36
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL426697 0.93 FAAH (0.44) FAAHGPBAR1LMNATP53SMN1; SMN2
SCHEMBL425550 0.84 FAAH (0.51) FAAHGPBAR1LMNATP53SMN1; SMN2
SCHEMBL427152 0.80 FAAH (0.42) FAAHGPBAR1LMNATP53MLNR
SCHEMBL426706 0.79 GPBAR1 (0.46) FAAHGPBAR1LMNATP53MLNR
SCHEMBL425556 0.77 L3MBTL1 (0.43) FAAHLMNATP53L3MBTL1
SCHEMBL425371 0.76 FAAH (0.60) FAAHLMNATP53SMN1; SMN2KDM4E
SCHEMBL427476 0.74 FAAH (0.57) FAAHLMNATP53SMN1; SMN2KDM4E
SCHEMBL16212908 0.73 USP19 (0.45) GRIN2BUSP19ADORA3ADORA2AADORA2B
SCHEMBL426698 0.72 FAAH (0.52) FAAHLMNATP53SMN1; SMN2KDM4E
SCHEMBL425544 0.72 FAAH (0.52) FAAHTP53ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9353082-B2 Pharmaceutical compounds BIAL—PORTELA & CA, S.A. (PT) 2016-05-31 US disclosed
US-9353082-B2 Pharmaceutical compounds BIAL—PORTELA & CA, S.A. (PT) 2016-05-31 US disclosed
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS BIAL - PORTELA & Cª, S.A. (PT) 2012-03-15 US disclosed
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS BIAL - PORTELA & Cª, S.A. (PT) 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS FAAH, FAAH2, ASAH1 FAAH 1/4885GPBAR1 218/4885LMNA 2523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.